Jasper Therapeutics Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Biotechnology
Headquarters
United States of America US
Employees
22
IPO date
Nov 20, 2019

Jasper Therapeutics is a biotechnology company developing antibody-based medicines, with its lead program built around briquilimab, an antibody that targets the c-Kit receptor on stem cells and mast cells. The company is trying to use that biology in two main ways: to help prepare patients for stem cell transplant without traditional chemotherapy, and to treat diseases driven by mast cells, such as certain allergic and inflammatory conditions. Its main customers would be hospitals, transplant centers, and specialist doctors if its drugs reach the market.

The company does not sell a broad product line today; it is focused on advancing drug candidates through clinical development and regulatory review. If approved, it would make money by selling its medicines to healthcare providers and payers, usually through the standard drug pricing and reimbursement system. That means Jasper’s business depends on proving that its treatments are safe, effective, and better tolerated than older conditioning or immune-suppressing approaches.

What makes Jasper’s role different is that it sits at the front end of the treatment chain, where it is trying to replace or simplify a difficult medical preparation step rather than treat only the disease after the fact. In plain terms, it aims to make certain transplants and mast-cell-related diseases easier to manage by targeting the cells that drive them with a single engineered antibody.

Jasper Therapeutics Inc Investor Relations

Address
2200 Bridge Pkwy Suite #102
Redwood City, California
United States of America

Business Segments

Therapeutic antibody development

Jasper Therapeutics develops antibody-based medicines, led by briquilimab, for blood, immune, and stem cell transplant uses. The company studies these treatments in clinical trials and works toward future approval and co...

Customers and revenue model

Management

Mr. Ronald A. Martell

President, CEO & Director

Biography unavailable

Dr. Judith Anne Shizuru M.D., Ph.D.

Co-Founder & Director

Biography unavailable

Mr. Jeetinder Singh Mahal M.B.A.

Chief Operating Officer

Biography unavailable

Dr. Edwin Jonathan Tucker M.D.

Chief Medical Officer

Biography unavailable

Mr. Herbert C. Cross CPA

CFO & Corporate Secretary

Biography unavailable

Dr. Luca Di Noto Ph.D.

Senior Vice President of Technical Operations

Biography unavailable

Mr. David Ku M.D.

Vice President of Corporate Development, Portfolio Strategy & Management

Biography unavailable

Mr. Matthew Ford

Vice President of Human Resources

Biography unavailable

Dr. Wendy Pang M.D., Ph.D.

Senior Vice President of Research & Translational Medicine

Biography unavailable

Ms. Patricia Carlos

Senior Vice President of Regulatory Affairs & Quality

Biography unavailable

1 / 10